We are live on ! Find out more
AH

Aviva Holdings Portfolio holdings

AUM $20.5M
1-Year Est. Return 117.01%
This Fund
S&P 500
This Quarter Est. Return
+40.2%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$75.7M
Cap. Flow
+$7.22M
Cap. Flow %
2.93%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$9.31M
2
MGNX icon
MacroGenics
MGNX
+$4.62M
3
PTCT icon
PTC Therapeutics
PTCT
+$2.21M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$8.92M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$111M 45.08%
3,373,397
+298,095
+10% +$9.31M
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$96.3M 39.06%
3,135,966
– –
MGNX icon
3
MacroGenics
MGNX
$263M
$24.6M 9.98%
977,426
+190,166
+24% +$4.62M
ESPR
4
DELISTED
Esperion Therapeutics
ESPR
$12.1M 4.92%
167,587
-121,513
-42% -$8.92M
PTCT icon
5
PTC Therapeutics
PTCT
$5.98B
$2.36M 0.96%
+87,330
New +$2.21M

Similar funds

MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return

Aviva Holdings's Q1 2018 Portfolio in Review

As of Q1 2018, Aviva Holdings held 5 positions worth $246M, up 44% from $171M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aviva Holdings's Q1 2018 filing shows 1 new, 2 increased and 1 reduced positions. Its largest new stake was PTC Therapeutics: 87,330 shares worth $2.36M. The largest sale was Esperion Therapeutics, an estimated $8.92M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Aviva Holdings's largest Q1 2018 buy was PTC Therapeutics: 87,330 shares worth $2.36M.
  • Aviva Holdings added most to Medicines Co in Q1 2018, an estimated $9.31M increase.
  • Aviva Holdings's biggest Q1 2018 reduction was Esperion Therapeutics, cutting an estimated $8.92M.
  • Aviva Holdings's ten largest holdings make up 100% of its $246M portfolio in Q1 2018.
  • Aviva Holdings opened 1 new position and closed 0 in Q1 2018.
  • Aviva Holdings's portfolio value rose 44% quarter-over-quarter to $246M.

Based on Aviva Holdings's 13F filing for Q1 2018, filed 15 May 2018.